Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats
- 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt
- 2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
- 3Department of Pharmacology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
- 4Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt
- 5Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
A Corrigendum on
Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats
By Ewees MG, Messiha BAS, Abo-Saif AA, Bayoumi AMA and Abdel-Bakky MS (2018). Front. Pharmacol. 9:1155. doi: 10.3389/fphar.2018.01155
In the published article, there was an error in affiliation “1” and “2.” “Beni-Suef” was incorrectly written as “Beni Suef.” In affiliation 1, instead of “Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni Suef, Egypt,” it should be “Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.” In affiliation 2, instead of “Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni Suef University, Beni Suef, Egypt,” it should be “Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni Suef University, Beni-Suef, Egypt.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: coagulation cascade, cisplatin, rivaroxaban, fibrin, tissue factor, nephrotoxicity
Citation: Ewees MG, Messiha BAS, Abo-Saif AA, Bayoumi AMA and Abdel-Bakky MS (2019) Corrigendum: Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats. Front. Pharmacol. 10:1259. doi: 10.3389/fphar.2019.01259
Received: 06 September 2019; Accepted: 30 September 2019;
Published: 24 October 2019.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2019 Ewees, Messiha, Abo-Saif, Bayoumi and Abdel-Bakky. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mohamed G. Ewees, Mohamed_pharma86@yahoo.com